The Effects of Glycerol as an Optical Clearing Agent for Visualization of the Middle Ear
NCT05497934 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2024-08-21
Summary
This study will examine the improvement in middle ear optical coherence tomography imaging from the topical application of glycerol to the tympanic membrane in normal, opaque and post-operative ears
Conditions
- Tympanosclerosis
- Thickened Ears
- Healthy
- Surgery
Interventions
- DRUG
-
Glycerol
In this study, 99.5% pure glycerol will be used as an optical clearing agent. The glycerol will be applied topically to the tympanic membrane.
Sponsors & Collaborators
-
Dalhousie University
collaborator OTHER -
Nova Scotia Health Authority
lead OTHER
Principal Investigators
-
David P Morris, MD · Nova Scotia Health Authority
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2023-10-01
- Completion
- 2024-03-31
More Related Trials
-
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
NCT02038972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss
NCT02132130 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
NCT06249919 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
NCT04960384 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of LY3056480 in Patients With SNLH
NCT05061758 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations
NCT05788536 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Usability of the Intracochlear Catheter INCAT - a Feasibility Study
NCT06218966 ·Status: UNKNOWN ·Phase: NA
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty
NCT05967845 ·Status: COMPLETED ·Phase: NA
-
Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss
NCT02997189 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)
NCT02829294 ·Status: COMPLETED ·Phase: NA
-
Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
NCT02811549 ·Status: COMPLETED ·Phase: NA
-
The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults
NCT02941627 ·Status: COMPLETED ·Phase: NA
-
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
NCT04766853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Feasibility of Middle Ear OCT Imaging
NCT05445388 ·Status: UNKNOWN ·Phase: NA
-
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
NCT03958006 ·Status: COMPLETED ·Phase: NA
-
Action of Intra-auricular Topical Lidocaine on Tinnitus
NCT05711641 ·Status: COMPLETED ·Phase: NA
-
CI Following VS Removal or Labyrinthectomy
NCT03795675 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
The EarLens Contact Hearing Device (CHD) Spectrum Study
NCT02470494 ·Status: COMPLETED ·Phase: NA
-
Caroverin and Inner Ear Diseases
NCT01174979 ·Status: SUSPENDED ·Phase: PHASE3
-
Single-sided Deafness and Cochlear Implantation
NCT05052944 ·Status: COMPLETED
-
FX-322 in Adults With Severe Sensorineural Hearing Loss
NCT04629664 ·Status: COMPLETED ·Phase: PHASE1
-
CNS Infections Effect on the Inner Ear
NCT03715569 ·Status: UNKNOWN